Answers are grounded in this paper and cite their sources.
Perspective highlights exercise barriers impacting weight loss and adherence in patients using GLP-1 receptor agonists.
This Perspective describes the challenges of prescribing exercise for weight loss, with and without the use of glucagon-like peptide 1 (GLP-1) receptor agonists, and discusses strategies clinicians can use to improve adherence to exercise recommendations.
No takes yet. Share an insight, caveat, or question.
Lieberman et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: